Drug Trial Radar · NCT01546142
Phase 3 Study of Deoxycholic Acid Injection (ATX-101) Versus Placebo for the Reduction of Localized Subcutaneous Fat in the Submental Area
Last checked: Nov 19, 2026Latest source record: Jun 15, 2015 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
516
Actual
Start
Mar 2012
Primary completion
May 2013
Study completion Aug 2013
Sponsor
- Lead sponsor
- Kythera BiopharmaceuticalsIndustry
- Sponsor type
- Industry
- First posted
- Mar 7, 2012
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
To evaluate the safety and efficacy of deoxycholic acid injection in the reduction of submental fat (fat below the chin).
Conditions
- Moderate or Severe Submental Fullness
Interventions
Deoxycholic acid injectionDrug
Formulated as an injectable solution containing deoxycholic acid at a concentration of 10 mg/mL.
PlaceboDrug
Phosphate buffered saline placebo for injection
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Who Achieved a Composite 1-grade ResponseTime frame: Baseline and 12 weeks after last treatment (up to 32 weeks after first treatment)
- Percentage of Participants Who Achieved a Composite 2-grade ResponseTime frame: Baseline and 12 weeks after last treatment (up to 32 weeks after first treatment)
Locations
35 sites in 2 countries. Site status is shown where the registry gives one.
Investigational Site
Little Rock, Arkansas
Investigational Site
Beverly Hills, California
Investigational Site
Los Angeles, California
Investigational Site
Sacramento, California
Investigational Site
San Francisco, California
Investigational Site
Santa Monica, California
Investigational Site
Englewood, Colorado
Investigational Site
Coral Gables, Florida
Investigational Site
Jacksonville, Florida
Investigational Site
Chicago, Illinois
Investigational Site
Naperville, Illinois
Investigational Site
Carmel, Indiana
Investigational Site
South Bend, Indiana
Investigational Site
Lutherville, Maryland
Investigational Site
Clinton Township, Michigan
Investigational Site
Edina, Minnesota
Investigational Site
St Louis, Missouri
Investigational Site
Montclair, New Jersey
Investigational Site
New York, New York
Investigational Site
New York, New York
Investigational Site
White Plains, New York
Investigational Site
Charlotte, North Carolina
Investigational Site
High Point, North Carolina
Investigational Site
Cincinnatti, Ohio
Investigational Site
Portland, Oregon
Investigational Site
Austin, Texas
Investigational Site
Plano, Texas
Investigational Site
San Antonio, Texas
Investigational Site
Salt Lake City, Utah
Investigational Site
Charlottesville, Virginia
Investigational Site
Calgary, Alberta, Canada
Investigational Site
Surrey, British Columbia, Canada
Investigational Site
Vancouver, British Columbia, Canada
Investigational Site
Oakville, Ontario, Canada
Investigational Site
Woodbridge, Ontario, Canada
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.